Wells Fargo’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Wells Fargo’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-31,900	Closed	-$941K	–	7138
2019 Q4	$941K	Hold	31,900	–	–	﹤0.01%	3897
2019 Q3	$798K	Hold	31,900	–	–	﹤0.01%	4018
2019 Q2	$167K	Buy	+31,900	New	+$5.52M	﹤0.01%	5076
2018 Q4	–	Sell	-2,900	Closed	-$20K	–	6727
2018 Q3	$20K	Sell	2,900 -12,100	-81%	-$1.74M	﹤0.01%	5831
2018 Q2	$306K	Buy	+15,000	New	+$2.13M	﹤0.01%	4785

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Wells Fargo's GWPH Position: Q2 2021 in Review

Wells Fargo sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 71,779 shares — an estimated $15.6M sold.

Wells Fargo first reported a position in GWPH in Q4 2013 and held it in 30 quarters. The position peaked at $53.1M in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Wells Fargo reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Wells Fargo sold 71,779 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $15.6M.
Wells Fargo first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2013 and held it in 30 quarters.
Wells Fargo's GW Pharmaceuticals Plc American Depositary Shares position peaked at $53.1M in Q3 2018.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Wells Fargo's 13F filing for Q2 2021, filed 16 Aug 2021.